In summary, these findings argue for an improvement of hepatic but not systemic insulin sensitivity and show that intestinal Ces2c overexpression protects mice from HFD‐induced NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.